You are here: Industry Insights > SARS-CoV-2

News List

New England Journal of Medicine Publishes Positive Phase 3 Trial Results for REGEN-COV (casirivimab and imdevimab) to Prevent SARS-CoV-2 Infection firstwordpharma
August 05, 2021
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the New England Journal of Medicine(NEJM) published positive detailed results from a Phase 3 trial that assessed the ability of REGEN-COV™ (casirivimab and imdevimab) to prevent COVID-19.
Miller School Research Reveals that Flu Shot Protects Against Severe Effects of COVID-19 firstwordpharma
August 05, 2021
In a newly published study, physician-scientists at the University of Miami Miller School of Medicine have shown that the flu vaccine may provide vital protection against COVID-19.
Bio-Techne's RNAscope™ Technology Aids in the Retrospective Tissue Diagnosis of COVID-19 in cases with no previous testing for SARS-CoV-2 prnewswire
August 05, 2021
Bio-Techne Corporation (NASDAQ: TECH) today announced that scientists at the U.S. Centers for Disease Control and Prevention (CDC) recently highlighted the importance of fixed tissue analysis for retrospective diagnosis of SARS-CoV-2 infection
Clinical Trial Affirms CoviDTH Diagnostic Approach to screen for T cell-mediated immune response to SARS-CoV-2 is safe and effective in humans prnasia
August 04, 2021
BioVaxys Technology Corp. is pleased to announce that Immunologist Yvelise Barrios, MD, PhD, a specialist in Clinical Immunology at Hospital Universitario de Canarias, Tenerife, Spain, has joined BioVaxys as a Scientific Adviser to support development ...
Varigard Technologies Proven to Prevent the Tactile Spread of SARS-CoV-2, B.1.617.2 - DELTA Variant prnasia
August 04, 2021
Varigard and Synergy Laboratories have announced the test results of an advanced hand sanitizing gel and surface disinfectant.
AAP Provides Guidance for Follow-Up Care for Pediatric COVID-19 drugs
August 04, 2021
Children with severe acute respiratory syndrome coronavirus 2 infection should receive pediatric follow-up care to monitor for symptom resolution and screen for and address health concerns, according to guidance published by American Academy of Pediatrics
Rethinking Remdesivir firstwordpharma
August 04, 2021
Remdesivir is an antiviral drug originally discovered as part of a program to develop antiviral agents with activity against novel emerging viruses.
Existing Drug Is Shown to Inhibit Virus That Causes COVID-19 firstwordpharma
August 03, 2021
Scientists from the University of Chicago have found that the drug masitinib may be effective in treating COVID-19.
Thinking impaired in 60% of COVID-19 survivors worldpharmanews
August 02, 2021
In a sample of over 400 older adults in Argentina who had recovered from COVID-19, more than 60% displayed some degree of cognitive impairment, a researcher from The University of Texas Health Science Center at San Antonio reported July 29 at the ...
Provincetown Outbreak Shows Delta Can Spread Among Vaccinated, But Cases Are Mild drugs
August 02, 2021
The Cape Cod resort town of Provincetown draws big crowds every summer. In July, those largely vaccinated crowds -- packed into bars, restaurants and private homes -- were the genesis of an outbreak of the Delta variant that could be a sobering model.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 61 62 Next page